Growth Metrics

DBV Technologies (DBVT) Current Assets (2014 - 2026)

DBV Technologies (DBVT) reported Current Assets of $246.7 million for Q1 2026, up 746.37% year-over-year from $29.1 million in Q1 2025, and up 15.88% on a QoQ basis from $212.9 million in Q4 2025.

DBV Technologies (DBVT) has 13 years of Current Assets data on file, last reported at $246.7 million in Q1 2026.

  • Quarterly Current Assets rose 746.37% year-over-year to $246.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $246.7 million (up 746.37% YoY) and the FY2025 annual result came in at $212.9 million, up 379.63% from the prior year.
  • Current Assets grew to $246.7 million in Q1 2026 per DBVT's latest filing, from $212.9 million in the prior quarter.
  • Across five years, Current Assets topped out at $260.0 million in Q2 2022 and bottomed at $29.1 million in Q1 2025.
  • The 5-year median for Current Assets is $158.9 million (2023), against an average of $150.3 million.
  • The widest annual swing landed in 2025, when Current Assets plunged 75.62%; it then jumped 746.37% in 2026.
  • Tracing DBVT's Current Assets over 5 years: stood at $223.1 million in 2022, then slipped by 28.76% to $158.9 million in 2023, then tumbled by 72.07% to $44.4 million in 2024, then surged by 379.63% to $212.9 million in 2025, then gained by 15.88% to $246.7 million in 2026.
  • Per Business Quant, the three latest DBVT Current Assets figures stand at $246.7 million (Q1 2026), $212.9 million (Q4 2025), and $88.9 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 10.37 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 37.31 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 1.25 Bn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 73.04 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 3.59 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 11.73 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 18.21 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 4.22 Bn
10 DBV Technologies 8.00 Bn 7.77 Bn -3.90 Mn 246.70 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 246.70 Mn
Dec 31, 2025 212.90 Mn
Sep 30, 2025 88.88 Mn
Jun 30, 2025 121.24 Mn
Mar 31, 2025 29.15 Mn
Dec 31, 2024 44.39 Mn
Sep 30, 2024 68.76 Mn
Jun 30, 2024 89.96 Mn
Mar 31, 2024 119.56 Mn
Dec 31, 2023 158.92 Mn
Sep 30, 2023 169.27 Mn
Jun 30, 2023 195.54 Mn
Mar 31, 2023 210.24 Mn
Dec 31, 2022 223.07 Mn
Sep 30, 2022 225.70 Mn
Jun 30, 2022 259.95 Mn
Mar 31, 2022 90.44 Mn
Dec 31, 2021 114.39 Mn
Sep 30, 2021 110.14 Mn
Jun 30, 2021 138.59 Mn
Mar 31, 2021 159.81 Mn
Dec 31, 2020 207.38 Mn
Jun 30, 2020 262.08 Mn
Dec 31, 2019 201.55 Mn
Sep 30, 2019 107.36 Mn
Jun 30, 2019 154.54 Mn
Dec 31, 2018 166.04 Mn
Jun 30, 2018 274.83 Mn
Dec 31, 2017 184.70 Mn
Jun 30, 2017 241.20 Mn
Dec 31, 2016 293.88 Mn
Jun 30, 2016 355.68 Mn
Dec 31, 2015 367.08 Mn
Jun 30, 2015 126.73 Mn
Dec 31, 2014 151.94 Mn